These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

103 related items for PubMed ID: 29103508

  • 21. A Novel Approach for Analyzing the Dissolution Mechanism of Solid Dispersions.
    Ji Y, Paus R, Prudic A, Lübbert C, Sadowski G.
    Pharm Res; 2015 Aug; 32(8):2559-78. PubMed ID: 25715696
    [Abstract] [Full Text] [Related]

  • 22. Impregnation of Fenofibrate on mesoporous silica using supercritical carbon dioxide.
    Bouledjouidja A, Masmoudi Y, Van Speybroeck M, Schueller L, Badens E.
    Int J Pharm; 2016 Feb 29; 499(1-2):1-9. PubMed ID: 26732521
    [Abstract] [Full Text] [Related]

  • 23. Effect of the solid-dispersion method on the solubility and crystalline property of tacrolimus.
    Joe JH, Lee WM, Park YJ, Joe KH, Oh DH, Seo YG, Woo JS, Yong CS, Choi HG.
    Int J Pharm; 2010 Aug 16; 395(1-2):161-6. PubMed ID: 20580799
    [Abstract] [Full Text] [Related]

  • 24. Use of surfactants as plasticizers in preparing solid dispersions of poorly soluble API: stability testing of selected solid dispersions.
    Ghebremeskel AN, Vemavarapu C, Lodaya M.
    Pharm Res; 2006 Aug 16; 23(8):1928-36. PubMed ID: 16871443
    [Abstract] [Full Text] [Related]

  • 25. High-Throughput Raman Spectroscopy Screening of Excipients for the Stabilization of Amorphous Drugs.
    Chen X, Stoneburner K, Ladika M, Kuo TC, Kalantar TH.
    Appl Spectrosc; 2015 Nov 16; 69(11):1271-80. PubMed ID: 26647050
    [Abstract] [Full Text] [Related]

  • 26. Dendrimer nanotechnology for enhanced formulation and controlled delivery of resveratrol.
    Chauhan AS.
    Ann N Y Acad Sci; 2015 Aug 16; 1348(1):134-40. PubMed ID: 26173478
    [Abstract] [Full Text] [Related]

  • 27. Impact of sodium dodecyl sulphate on the dissolution of poorly soluble drug into biorelevant medium from drug-surfactant discs.
    Madelung P, Ostergaard J, Bertelsen P, Jørgensen EV, Jacobsen J, Müllertz A.
    Int J Pharm; 2014 Jun 05; 467(1-2):1-8. PubMed ID: 24594297
    [Abstract] [Full Text] [Related]

  • 28. Micellar solubilization of poorly water-soluble drugs: effect of surfactant and solubilizate molecular structure.
    Vinarov Z, Katev V, Radeva D, Tcholakova S, Denkov ND.
    Drug Dev Ind Pharm; 2018 Apr 05; 44(4):677-686. PubMed ID: 29164955
    [Abstract] [Full Text] [Related]

  • 29. Preparation and characterization of emulsified solid dispersions containing docetaxel.
    Chen Y, Shi Q, Chen Z, Zheng J, Xu H, Li J, Liu H.
    Arch Pharm Res; 2011 Nov 05; 34(11):1909-17. PubMed ID: 22139690
    [Abstract] [Full Text] [Related]

  • 30. Theoretical and practical approaches for prediction of drug-polymer miscibility and solubility.
    Marsac PJ, Shamblin SL, Taylor LS.
    Pharm Res; 2006 Oct 05; 23(10):2417-26. PubMed ID: 16933098
    [Abstract] [Full Text] [Related]

  • 31. Continuous and scalable process for water-redispersible nanoformulation of poorly aqueous soluble APIs by antisolvent precipitation and spray-drying.
    Hu J, Ng WK, Dong Y, Shen S, Tan RB.
    Int J Pharm; 2011 Feb 14; 404(1-2):198-204. PubMed ID: 21056643
    [Abstract] [Full Text] [Related]

  • 32. Transformation of acidic poorly water soluble drugs into ionic liquids.
    Balk A, Wiest J, Widmer T, Galli B, Holzgrabe U, Meinel L.
    Eur J Pharm Biopharm; 2015 Aug 14; 94():73-82. PubMed ID: 25976317
    [Abstract] [Full Text] [Related]

  • 33. Current trends and future perspectives of solid dispersions containing poorly water-soluble drugs.
    Vo CL, Park C, Lee BJ.
    Eur J Pharm Biopharm; 2013 Nov 14; 85(3 Pt B):799-813. PubMed ID: 24056053
    [Abstract] [Full Text] [Related]

  • 34. A mechanistic study of griseofulvin dissolution into surfactant solutions under laminar flow conditions.
    Rao VM, Lin M, Larive CK, Southard MZ.
    J Pharm Sci; 1997 Oct 14; 86(10):1132-7. PubMed ID: 9344170
    [Abstract] [Full Text] [Related]

  • 35. Role of surfactant and pH on dissolution properties of fenofibrate and glipizide--a technical note.
    Jamzad S, Fassihi R.
    AAPS PharmSciTech; 2006 Apr 07; 7(2):E33. PubMed ID: 16796351
    [Abstract] [Full Text] [Related]

  • 36. Use of Spray-Dried Dispersions in Early Pharmaceutical Development: Theoretical and Practical Challenges.
    Li J, Patel D, Wang G.
    AAPS J; 2017 Mar 07; 19(2):321-333. PubMed ID: 27896684
    [Abstract] [Full Text] [Related]

  • 37. Fabrication and evaluation of celecoxib microparticle surface modified by hydrophilic cellulose and surfactant.
    Ha ES, Ok J, Noh J, Jeong HY, Choo GH, Jung YS, Baek IH, Kim JS, Cho W, Hwang SJ, Kim MS.
    Int J Biol Macromol; 2015 Jan 07; 72():1473-8. PubMed ID: 25451745
    [Abstract] [Full Text] [Related]

  • 38. A comparison between pure active pharmaceutical ingredients and therapeutic deep eutectic solvents: Solubility and permeability studies.
    Duarte AR, Ferreira AS, Barreiros S, Cabrita E, Reis RL, Paiva A.
    Eur J Pharm Biopharm; 2017 May 07; 114():296-304. PubMed ID: 28189620
    [Abstract] [Full Text] [Related]

  • 39. Poorly water-soluble drug nanoparticles via solvent evaporation in water-soluble porous polymers.
    Roberts AD, Zhang H.
    Int J Pharm; 2013 Apr 15; 447(1-2):241-50. PubMed ID: 23499755
    [Abstract] [Full Text] [Related]

  • 40. Thermodynamic phase behavior of API/polymer solid dispersions.
    Prudic A, Ji Y, Sadowski G.
    Mol Pharm; 2014 Jul 07; 11(7):2294-304. PubMed ID: 24870944
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.